Stock listing

OTC:NGSX NeurogesX Inc Stock

Follow NeurogesX Inc into a list and get an email when it puts out news.

Delisted OTC:NGSX no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.

Ticker
OTC:NGSX
Asset type
Stock
Exchange
OTC
Currency
USD

NeurogesX Inc on 6ix

Decks
2 decks · latest Nov 8, 2011

Decks

DeckKindSlidesDate
Technical Presentation (November 2011)Technical9 slidesNov 8, 2011
J P Morgan 28th Annual Healthcare Conference (January 2010)Conference33 slidesJan 14, 2010

Open Decks

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Gary A. Lyons
Other companies: Travere Therapeutics, Inc. (Director · Since at least Oct 8, 2014); Neurocrine Biosciences, Inc. (Director · Since at least May 25, 2010); Brickell Biotech Inc (Director · Feb 14, 2020 – May 17, 2022 · Past); Eledon Pharmaceuticals, Inc. (Director · May 10, 2017 – May 1, 2023 · Past); Humanigen Inc (Director · Aug 10, 2012 – Jul 10, 2015 · Past); Rigel Pharmaceuticals, Inc. (Director · May 28, 2010 – May 26, 2023 · Past); Vical Incorporated (Director · May 25, 2010 – May 23, 2018 · Past); Facet Biotech Corp (Director · Apr 20, 2010 – Apr 21, 2010 · Past)
Director · Apr 27, 2011 – Jun 7, 2012 · Past

Open People

Log in to ask 6ix AI your own questions about NeurogesX Inc.